PMC:7075884 / 29574-29931 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1056","span":{"begin":165,"end":176},"obj":"Species"},{"id":"1057","span":{"begin":189,"end":193},"obj":"Species"},{"id":"1058","span":{"begin":195,"end":199},"obj":"Species"},{"id":"1059","span":{"begin":335,"end":340},"obj":"Species"},{"id":"1060","span":{"begin":342,"end":347},"obj":"Species"},{"id":"1061","span":{"begin":201,"end":204},"obj":"Species"},{"id":"1062","span":{"begin":352,"end":355},"obj":"Species"},{"id":"1063","span":{"begin":42,"end":44},"obj":"Chemical"},{"id":"1064","span":{"begin":98,"end":100},"obj":"Chemical"},{"id":"1066","span":{"begin":60,"end":76},"obj":"Disease"},{"id":"1067","span":{"begin":142,"end":158},"obj":"Disease"},{"id":"1068","span":{"begin":178,"end":186},"obj":"Disease"}],"attributes":[{"id":"A1056","pred":"tao:has_database_id","subj":"1056","obj":"Tax:11118"},{"id":"A1057","pred":"tao:has_database_id","subj":"1057","obj":"Tax:1570291"},{"id":"A1058","pred":"tao:has_database_id","subj":"1058","obj":"Tax:64320"},{"id":"A1059","pred":"tao:has_database_id","subj":"1059","obj":"Tax:10298"},{"id":"A1060","pred":"tao:has_database_id","subj":"1060","obj":"Tax:10310"},{"id":"A1061","pred":"tao:has_database_id","subj":"1061","obj":"Tax:11320"},{"id":"A1062","pred":"tao:has_database_id","subj":"1062","obj":"Tax:10335"},{"id":"A1063","pred":"tao:has_database_id","subj":"1063","obj":"MESH:C112485"},{"id":"A1064","pred":"tao:has_database_id","subj":"1064","obj":"MESH:C112485"},{"id":"A1066","pred":"tao:has_database_id","subj":"1066","obj":"MESH:D001102"},{"id":"A1067","pred":"tao:has_database_id","subj":"1067","obj":"MESH:D001102"},{"id":"A1068","pred":"tao:has_database_id","subj":"1068","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Thus, in light of the antiviral effect of GA on established viral infections of permissive cells, GA potentially could be used to treat acute viral infections (e.g. Coronavirus (COVID-19), EBOV, ZIKV, IAV and measles), and it might be determined to be useful in topical application for the successful treatment of active lesions (e.g. HSV-1, HSV-2 and VZV)."}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T239","span":{"begin":91,"end":96},"obj":"Body_part"}],"attributes":[{"id":"A239","pred":"fma_id","subj":"T239","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Thus, in light of the antiviral effect of GA on established viral infections of permissive cells, GA potentially could be used to treat acute viral infections (e.g. Coronavirus (COVID-19), EBOV, ZIKV, IAV and measles), and it might be determined to be useful in topical application for the successful treatment of active lesions (e.g. HSV-1, HSV-2 and VZV)."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T70","span":{"begin":60,"end":76},"obj":"Disease"},{"id":"T71","span":{"begin":142,"end":158},"obj":"Disease"},{"id":"T72","span":{"begin":178,"end":186},"obj":"Disease"},{"id":"T73","span":{"begin":209,"end":216},"obj":"Disease"}],"attributes":[{"id":"A70","pred":"mondo_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A71","pred":"mondo_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A72","pred":"mondo_id","subj":"T72","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A73","pred":"mondo_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/MONDO_0004619"}],"text":"Thus, in light of the antiviral effect of GA on established viral infections of permissive cells, GA potentially could be used to treat acute viral infections (e.g. Coronavirus (COVID-19), EBOV, ZIKV, IAV and measles), and it might be determined to be useful in topical application for the successful treatment of active lesions (e.g. HSV-1, HSV-2 and VZV)."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T454","span":{"begin":91,"end":96},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T455","span":{"begin":314,"end":320},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"Thus, in light of the antiviral effect of GA on established viral infections of permissive cells, GA potentially could be used to treat acute viral infections (e.g. Coronavirus (COVID-19), EBOV, ZIKV, IAV and measles), and it might be determined to be useful in topical application for the successful treatment of active lesions (e.g. HSV-1, HSV-2 and VZV)."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T752","span":{"begin":22,"end":31},"obj":"Chemical"},{"id":"T753","span":{"begin":42,"end":44},"obj":"Chemical"},{"id":"T756","span":{"begin":98,"end":100},"obj":"Chemical"},{"id":"T759","span":{"begin":270,"end":281},"obj":"Chemical"}],"attributes":[{"id":"A752","pred":"chebi_id","subj":"T752","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A753","pred":"chebi_id","subj":"T753","obj":"http://purl.obolibrary.org/obo/CHEBI_5206"},{"id":"A754","pred":"chebi_id","subj":"T753","obj":"http://purl.obolibrary.org/obo/CHEBI_73855"},{"id":"A755","pred":"chebi_id","subj":"T753","obj":"http://purl.obolibrary.org/obo/CHEBI_5354"},{"id":"A756","pred":"chebi_id","subj":"T756","obj":"http://purl.obolibrary.org/obo/CHEBI_5206"},{"id":"A757","pred":"chebi_id","subj":"T756","obj":"http://purl.obolibrary.org/obo/CHEBI_73855"},{"id":"A758","pred":"chebi_id","subj":"T756","obj":"http://purl.obolibrary.org/obo/CHEBI_5354"},{"id":"A759","pred":"chebi_id","subj":"T759","obj":"http://purl.obolibrary.org/obo/CHEBI_33232"}],"text":"Thus, in light of the antiviral effect of GA on established viral infections of permissive cells, GA potentially could be used to treat acute viral infections (e.g. Coronavirus (COVID-19), EBOV, ZIKV, IAV and measles), and it might be determined to be useful in topical application for the successful treatment of active lesions (e.g. HSV-1, HSV-2 and VZV)."}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T138","span":{"begin":60,"end":76},"obj":"http://purl.obolibrary.org/obo/GO_0016032"},{"id":"T139","span":{"begin":142,"end":158},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":"Thus, in light of the antiviral effect of GA on established viral infections of permissive cells, GA potentially could be used to treat acute viral infections (e.g. Coronavirus (COVID-19), EBOV, ZIKV, IAV and measles), and it might be determined to be useful in topical application for the successful treatment of active lesions (e.g. HSV-1, HSV-2 and VZV)."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T211","span":{"begin":0,"end":357},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Thus, in light of the antiviral effect of GA on established viral infections of permissive cells, GA potentially could be used to treat acute viral infections (e.g. Coronavirus (COVID-19), EBOV, ZIKV, IAV and measles), and it might be determined to be useful in topical application for the successful treatment of active lesions (e.g. HSV-1, HSV-2 and VZV)."}